RNase P (Internal Control)

RNase P (Internal Control) Overview

RNase P is a human gene present in all nucleated cells and is commonly used as an internal control in PCR-based assays. Its amplification confirms that the sample contains human nucleic acid and that the nucleic acid extraction and PCR steps were successful. Please note that even though RNase P is a gold standard endogenous control for PCR assays, but it is not reliable in urine samples due to their typically low human DNA content. Assays using urine often require additional or alternative controls to ensure accurate validation of negative results (Vogels et al 2020, FDA 2023).

References

Vogels, C. B. F., Brito, A. F., Wyllie, A. L., Fauver, J. R., Ott, I. M., Kalinich, C. C., Petrone, M. E., Casanovas-Massana, A., Catherine Muenker, M., Moore, A. J., Klein, J., Lu, P., Lu-Culligan, A., Jiang, X., Kim, D. J., Kudo, E., Mao, T., Moriyama, M., Oh, J. E., Park, A., … Grubaugh, N. D. (2020). Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets. Nature microbiology, 5(10), 1299–1305. https://doi.org/10.1038/s41564-020-0761-6

Nalla, A. K., Casto, A. M., Huang, M. W., Perchetti, G. A., Sampoleo, R., Shrestha, L., Wei, Y., Zhu, H., Jerome, K. R., & Greninger, A. L. (2020). Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit https://journals.asm.org/doi/epub/10.1128/jcm.00557-20Journal of clinical microbiology58(6), e00557-20. https://doi.org/10.1128/JCM.00557-20

(Nalla et al 2020)

Products used to detect RNase P (Internal Control)

The emerging UTI PCR panel 1 is designed for multiplex in vitro assessment of four emerging uropathogens (A. schaalii, A. urogenitalis, G. sanguinis, and P. agglomerates), using real-time PCR.
The emerging UTI PCR panel 2 is designed for multiplex in vitro assessment of four emerging uropathogens (A. urinae, F. hominis, S. anginosis group, and W. neuii), using real-time PCR.
The large GI PCR panel is designed for qualitative multiplex in vitro assessment of common gastrointestinal microbiota, using real-time PCR
The large respiratory PCR Panel is designed for multiplex in vitro assessment of 9 common respiratory microbiota markers, using real-time PCR.
The x-large respiratory PCR panel is designed for multiplex in vitro assessment of 25 common respiratory microbiota and resistance markers, using real-time PCR.
The STI large PCR panel is designed for multiplex in vitro assessment of 9 common microbiota typically associated with transmission by sexual activity, using real-time PCR.
The UTI large PCR panel is designed for multiplex in vitro assessment of 24 common urinary tract microbiota, using real-time PCR.
The women’s health large PCR panel is designed for multiplex in vitro assessment of 37 common vaginal microbiota and resistance markers, using real-time PCR.
The wound large PCR panel is designed for multiplex in-vitro assessment of 30 microbiota associated with wounds or tissue damage, using real-time PCR.